TRIUMF Innovations is proud to announce that ARTMS Products Inc., one of its spin-off companies has raised US$3 million from Quark Venture Inc. and GF Securities, through their Global Health Science Fund.

This investment will allow ARTMS to help alleviate supply issues and stabilize the global supply chain of medical isotopes by enabling the local production of Tc-99m. using hospital-based medical cyclotrons, instead of nuclear reactors. Tc-99m is used globally in more than 80 percent of all nuclear medicine imaging procedures in areas such as cardiology, oncology, and neurology and has been subject to significant supply disruptions in recent years resulting in serious implications for patient care.

Read the press release HERE